Search filters

List of works by Luigi Quintieri

A new nitrobenzoxadiazole-based GSTP1-1 inhibitor with a previously unheard of mechanism of action and high stability

scientific article published on December 2017

Carteolol, a non-conventional partial agonist of beta(1)-adrenoceptors, relaxes phenylephrine-constricted rat aorta through antagonism at alpha(1)-adrenoceptors

scientific article published on 24 May 2008

Delivery of methoxymorpholinyl doxorubicin by interleukin 2-activated NK cells: effect in mice bearing hepatic metastases

scientific article published on March 1999

Editorial [Hot Topic: Enzymes as Useful Tools and Potential Targets in Cancer Chemotherapy (Guest Editor: P. Ruzza and L. Quintieri)]

scientific article published on 01 September 2009

Ethylene negatively regulates transcript abundance of ROP-GAP rheostat-encoding genes and affects apoplastic reactive oxygen species homeostasis in epicarps of cold stored apple fruits

scientific article

Flavonoids diosmetin and hesperetin are potent inhibitors of cytochrome P450 2C9-mediated drug metabolism in vitro.

scientific article published on 22 September 2010

Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes.

scientific article

Glutathione transferases as targets for cancer therapy.

scientific article published on September 2009

Hyperthermic Isolated Perfusion With Low-Dose Tumor Necrosis Factor α and Doxorubicin for the Treatment of Limb-Threatening Soft Tissue Sarcomas

article

Identification of molecular determinants of tumor sensitivity and resistance to anticancer drugs.

scientific article published on January 2007

In vitro evidence that carteolol is a nonconventional partial agonist of guinea pig cardiac beta1-adrenoceptors: a comparison with xamoterol.

scientific article

Inhibition of Cytochrome P450 2C8-mediated Drug Metabolism by the Flavonoid Diosmetin

scientific article published on 26 July 2011

Irreversible CYP3A inhibition accompanied by plasma protein-binding displacement: a comparative analysis in subjects with normal and impaired liver function.

scientific article published on 19 November 2008

LKB1 loss is associated with glutathione deficiency under oxidative stress and sensitivity of cancer cells to cytotoxic drugs and γ-irradiation

scientific article published on 15 September 2018

Metabolic effects of antiangiogenic drugs in tumors: therapeutic implications.

scientific article published on 04 March 2014

Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.

scientific article published on April 2010

Pharmacokinetics of intraperitoneal cisplatin and doxorubicin.

scientific article published on July 2003

R-warfarin anticoagulant effect

scientific article published on 11 May 2017

Sex-related differences in renal toxicodynamics in rodents.

scientific article published on 07 July 2012

Synthesis and characterisation of a new benzamide-containing nitrobenzoxadiazole as a GSTP1-1 inhibitor endowed with high stability to metabolic hydrolysis

scientific article published on 01 December 2019

Synthesis and preliminary in vitro biological evaluation of 4-[(4-hydroxyphenyl)sulfanyl]but-3-en-2-one, a 4-mercaptophenol derivative designed as a novel bifunctional antimelanoma agent.

scientific article published in August 2009

Synthesis, structure-activity relationships and biological evaluation of 7-phenyl-pyrroloquinolinone 3-amide derivatives as potent antimitotic agents.

scientific article

The nitrobenzoxadiazole derivative MC3181 blocks melanoma invasion and metastasis

scientific article published on 17 January 2017

Therapeutic effect of interleukin 12 on mouse haemangiosarcomas is not associated with an increased anti-tumour cytotoxic T-lymphocyte activity

scientific article published on February 1, 1998

Vanillin Analogues o-Vanillin and 2,4,6-Trihydroxybenzaldehyde Inhibit NFĸB Activation and Suppress Growth of A375 Human Melanoma.

scientific article published on November 2016

Virtual Cross-Linking of the Active Nemorubicin Metabolite PNU-159682 to Double-Stranded DNA.

scientific article published on 9 January 2017